.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Breez has maintained a strong presence in the California market, particularly in the Capsules category where it consistently held the second position from January to April 2025. This stability in ranking suggests a loyal customer base and effective product strategy. However, in the Edible category, Breez has not broken into the top 30, hovering around the 42nd and 43rd positions, which indicates a potential area for growth or reevaluation. In the Tincture & Sublingual category, Breez was ranked 14th in January but did not maintain a top 30 ranking in subsequent months, suggesting a decline in market presence or increased competition.
In Illinois, Breez's performance shows varied results across different categories. The brand maintained a strong fourth position in the Capsules category from January to March, but it did not appear in the top 30 in April, which could indicate a loss of market share or a shift in consumer preferences. Meanwhile, Breez entered the Edible category in March at the 50th position, which, while not in the top 30, suggests an initial entry point for potential growth. Interestingly, Breez appeared in the Tincture & Sublingual category at fourth position in February but did not maintain this ranking in other months, highlighting a potential inconsistency in demand or distribution. Additionally, the brand's presence in the Vapor Pens category was not within the top 30, suggesting limited traction in this segment.
Competitive Landscape
In the competitive landscape of cannabis capsules in California, Breez has consistently held the second rank from January to April 2025, showcasing a stable position in the market. Despite facing strong competition from top-ranked Level, which maintains the lead with higher sales figures, Breez has managed to outperform ABX / AbsoluteXtracts and Emerald Bay Extracts, which remain in third and fourth positions respectively. Notably, Breez's sales experienced a dip in February but rebounded in March, indicating resilience and a potential for growth. This consistent ranking suggests that Breez has a strong brand presence and customer loyalty, which could be leveraged to close the gap with Level and further solidify its market position.
Notable Products
In April 2025, the top-performing product from Breez was the Indica Extra Strength Tablet 50-Pack (1000mg) in the Capsules category, maintaining its number one position for four consecutive months with sales of 6825. The Hybrid Extra-Strength Tablet 50-Pack (1000mg) also retained its consistent second-place ranking since January. The Sativa Extra Strength Tablet 50-Pack (1000mg) followed, holding the third position unchanged from previous months. Notably, the CBD/THC/CBN 2:1:1 Nighttime Extra Strength Tablets 50-Pack made a significant leap to fourth place in April, having been unranked in the previous months. Meanwhile, the Indica Royal Mint 10-Pack (100mg) saw a slight decline, moving from fourth in January to fifth in April.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
